share_log

Morgan Stanley Reiterates Equal-Weight on Amicus Therapeutics, Maintains $15 Price Target

Morgan Stanley Reiterates Equal-Weight on Amicus Therapeutics, Maintains $15 Price Target

摩根士丹利重申对Amicus Therapeutics的同等权重,维持15美元的目标股价
Benzinga ·  2023/07/11 08:57

Morgan Stanley analyst Andrew Galler reiterates Amicus Therapeutics (NASDAQ:FOLD) with a Equal-Weight and maintains $15 price target.

摩根士丹利分析师安德鲁·盖勒重申了Amicus Therapeutics(纳斯达克股票代码:FOLD)的权重相当,并维持15美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发